РОЛЬ ИНТЕРФЕРОНОВ В РЕГУЛЯЦИИ ОСТЕОГЕННЫХ И ОСТЕОРЕЗОРБТИВНЫХ ПРОЦЕССОВ
Аннотация
Об авторах
Л. А. ДмитриеваРоссия
Е. Ю. Коршунова
Россия
В. Ф. Лебедев
Россия
Список литературы
1. Кетлинский С.А., Симбирцев А.С. Цитокины. — СПб.: Фолиант, 2008. — 549 с.
2. Abraham A.K., Ramanathan M., Weinstock-Guttman B., Mager D.E. Mechanisms of interferon-beta effects on bone homeostasis // Biochem. Pharmacol. -2009. - Vol. 77, N 12. - P. 1757-1762.
3. Borovecki F., Pecina-Slaus N., Vukicevic S. Biological mechanisms of bone and cartilage remodeling - genomic perspective // International Orthopaedics (SICOT). - 2007. - Vol. 31 - P. 799-805.
4. Fukada S.Y., Silva T.A., Garlet G.P., Rosa A.L. et al. Factors involved in the T helper type 1 and type
5. cell commitment and osteoclast regulation in inflammatory apical diseases // Oral Microbiol. Immunol. - 2009. - Vol. 24 (1). - P. 25-31.
6. Gao Y., Grassi F., Ryan M.R., Terauchi M. et al. IFN-y stimulates osteoclast formation and bone loss in vivo via antigen-driven T cell activation // J. Clin. Invest. - 2007. - Vol. 117. - P. 122-132.
7. Gowen M., MacDonald B.R., Russell G.G. Actions of recombinant human y-interferon and tumor necrosis factor a on the proliferation and osteoblastic characteristics of human trabecular bone cells in vitro // Arthritis Rheum. - 1988. - Vol. 31. - P. 1500-1507.
8. Gruber H.E., Hoelscher G., Ingram J.A., Chow Y. et al. 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro // J. Spine (Phila Pa 1976). - 2008. - Vol. 33 (7). - P. 755-765.
9. Ha H., Lee J.H., Kim H.N., Kwak H.B. et al. Stimulation by TLR5 modulates osteoclast differentiation through STAT1/IFN-beta // Immunol. - 2008. -Vol. 180 (3). - P. 1382-1389.
10. Horowitz M.C., Lorenzo J.A. B Lymphocytes and the skeleton // Ann NY Acad. Sci. - 2007. -Vol. 1117. - P. 82-93.
11. Horowitz M.C., Lorenzo J.A. Immunologic regulation of bone development // Adv. Exp. Med. Biol. - 2007. - Vol. 602. - P. 47-56.
12. Hukkanen M., Hughes F.J., Buttery L.D., Gross S.S. et al. Cytokine-stimulated expression of inducible nitric oxide synthase by mouse, rat, and human osteoblast-like cells and its functional role in osteoblast metabolic activity // Endocrinology. -1995. - Vol. 136 (12). - P. 5445-5453.
13. Iba K., Takada J., Yamashita T. Prospects of treatment using interferon for bone diseases // Nippon Rinsho. - 2006. - Vol. 64 (7). - P. 1275-1280.
14. Jr Key L.L., Ries W.L., Rodriguiz R.M., Hatcher H.C. Recombinant human interferon у therapy for osteopetrosis // J. Pediatr. - 1992. - Vol. 121. -P. 119-124.
15. Jr Key L.L., Rodriguiz R.M., Willi S.M., Wrigth N.M. et al. Long-term treatment of osteopetrosis with recombinant human interferon у // N. Engl. J. Med. - 1995. - Vol. 332. - P. 1594-1599.
16. Kalvakolanu D.V., Borden E.C. Interferons: cellular and molecular biology of their actions // In: Bertion, JR., editor. Encyclopedia Cancer. - 2002. -Vol. 2. - P. 511-521.
17. Kawase Y., Hoshino T., Yokota K. Bone malformations in interleukin-18 transgenic mice // J. Bone Miner Res. - 2003. - Vol. 18. - P. 975-983.
18. Li H., Gade P., Xiao W., Kalvakolanu D.V The Interferon Signaling Network and Transcription Factor C/EBP-p // Cell Mol. Immunol. - 2007. -Vol. 4 (6). - P. 407-418.
19. Liu C.J., Chang E., Yu J., Carlson C.S. et al. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation // J. Biol. Chem. - 2005. -Vol. 280 (4). - P. 2788-2796.
20. Lorenzo J., Horowitz M., Choi Y. Osteoimmunology: interactions of the bone and immune system // Endocr. Rev. - 2008. - Vol. 29. - P. 403-440.
21. Luan Y, Yu X.P., Yang N., Frenkel S. et al. Р204 protein overcomes the inhibition of core binding factor alpha-1-mediated osteogenic differentiation by Id helix-loop-helix proteins // Mol. Biol. Cell. - 2008. -Vol. 19 (5). - P. 2113-2126.
22. Makiishi-Shimobayashi C., Tsujimura T., Iwasaki T., Yamada N. et al. Interleukin-18 up-regulates osteoprotegerin expression in stromal/osteoblastic cells // Biochem. Biophy. Res. Comm. - 2001. -Vol. 281. - P. 361 -366.
23. Nanes M.S., McKoy W.M., Marx S.J. Inhibitory effects of tumor necrosis factor-a and interferon-γ on deoxyribonucleic acid and collagen synthesis by rat osteosarcoma cells (ROS 17/2.8) // Endocrinology. -1989. - Vol. 124. - P. 339-345.
24. Nii A., Reynolds D.A., Young H.A., Ward J.M. Osteochondrodysplasia occurring in transgenic mice expressing interferon-g // Vet. Pathol. - 1997. -Vol. 34. - P. 431 -441.
25. Oreffo R.O.C., Romberg S., Virdi A.S., Joyner C.J. et al. Effects of interferon alpha on human osteoprogenitor cell growth and differentiation in vitro // J. Cell. Biochem. - 1999. - Vol. 74. - P. 372-385.
26. Orozco A., Gemmell E., Bickel M., Seymour G.J. Interleukin 18 and periodontal disease // J. Dent. Res. - 2007. - Vol. 86. - P. 586-593.
27. Rifas L. T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization // Cell Biochem. - 2006. -Vol. 98 (4). - P. 706-714.
28. Ruiz C., Perez E., Garcfa-Martfnez O., Diaz-Rodrigues L. et al. Expression of cytokines IL-4, IL-12, IL-15, IL-18, and IFNgamma and modulation by different growth factors in cultured human osteoblast-like cells // J. Bone Miner Metab. - 2007. - Vol. 25 (5). -P. 286-292.
29. Sakai S., Takaishi H., Matsuzaki K. et al. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression // J. Bone Miner Metab. - 2009. -Vol. 27 (6). - P. 643-652.
30. Takahashi N., Mundy G.R., Roodman G.D. Recombinant human interferon-y inhibits formation of human osteoclast-like cells // J. Immunol. - 1986. -Vol. 137. - P. 3544-3549.
31. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology // Mol. Med. - 2005. - Vol. 83 (3). - P. 170-179.
32. Takayanagi H., Kim S., Matsuo K., Suzuki H. et al. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta // Nature. - 2002. -Vol. 416. - P. 744-749.
33. Takayanagi H., Ogasawara K., Hida S., Chiba T. et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-y // Nature. - 2000. - Vol. 408. - P. 600-605.
34. Takayanagi H., Sato K., Takaoka A., Taniguchi T. Interplay between interferon and other cytokine systems in bone metabolism // Immunol. Rev. - 2005. - Vol. 208. - P. 181-193.
35. Yamada N., Niwa S., Tsujimura T., Iwasaki T. et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity // Bone. - 2002. - Vol. 30. - P. 901-908.
36. Yamamura M., Kawashima M., Taniai M., Yamauchi H. et al. Interferon-y-inducing activity of interleukin-18 in the joint with rheumatoid arthritis // Arthritis Rheum. - 2001. - Vol. 44. -P. 275-285.
37. Yoshihara R., Shiozawa S., Imai Y., Fujita T. Tumor necrosis factor alpha and interferon gamma inhibit proliferation and alkaline phosphatase activity of human osteoblastic Sa-OS-2 cell line // Lymphokine Res. - 1990. - Vol. 9. - P. 59-66.
Рецензия
Для цитирования:
Дмитриева Л.А., Коршунова Е.Ю., Лебедев В.Ф. РОЛЬ ИНТЕРФЕРОНОВ В РЕГУЛЯЦИИ ОСТЕОГЕННЫХ И ОСТЕОРЕЗОРБТИВНЫХ ПРОЦЕССОВ. Acta Biomedica Scientifica. 2012;(5(2)):136-140.
For citation:
Dmitrieva L.A., Korshunova E.Yu., Lebedev V.F. ROLE OF INTERFERONS IN REGULATION OF OSTOGENIC AND OSTEORESORPTIVE PROCESSES. Acta Biomedica Scientifica. 2012;(5(2)):136-140. (In Russ.)